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Abstract A cathepsin D (CD) inhibitor was searched using
mouse embryonic fibroblasts deficient for CD. Synthetic DNA
fragments specifically inhibited CD activity in a dose-dependent
manner, but not the activities of other serine or cysteine
proteinases. Cathepsin E activity was also inhibited by DNA
fragments when hemoglobin was used as a substrate. CD
inhibition by DNA fragments appeared to be electrostatic in
nature and dependent on Tm values. Moreover, CD activity was
partly inhibited by exogenously ingested DNA fragments,
suggesting that DNA fragments with high Tm values are potent
inhibitors of CD in vitro and partly in vivo. ß 2002 Federation
of European Biochemical Societies. Published by Elsevier Sci-
ence B.V. All rights reserved.
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1. Introduction
Lysosomes, ubiquitous in all animal cells as an acidic com-
partment with limiting membranes are able to degrade un-
needed intra- and extracellular materials to biological mono-
mers and contain various types of proteinases except for
metalloproteinases. Most lysosomal proteinases are cysteine
proteinases, while cystatins which are known to be present
in intra- and extracellular milieu, act as cysteine proteinase
inhibitors [1]. No speci¢c inhibitors of aspartic and serine
proteinases in lysosomes have yet been found, although ser-
pins, an inhibitor family of serine proteinases, are present [2].
Cathepsin D (CD), a representative aspartic proteinase in
lysosomes, is widely distributed in tissue cells and has been
shown to be involved in aging and certain pathological situa-
tions in brain tissues [3,4]. A study of CD de¢cient (CD3/3)
mice has shown that CD plays a crucial role in the degrada-
tion of cellular metabolites especially in neurons of the central
nervous system [5^7]. However, little is known about the pres-
ence of endogenous inhibitors in mammalian cells.
In the course of a study to determine whether an endoge-
nous inhibitor of CD is present in mammalian cells using
CD3/3 mouse embryonic ¢broblasts (MEFCD3/3), we
noted that the activity of puri¢ed CD is signi¢cantly reduced
when measured in the presence of extracts of MEFCD3/3,
indicating that some inhibiting substance is present in these
extracts. In the present study, we report an analysis of
MEFCD3/3 to identify the speci¢c inhibitor of CD. We
conclude that CD is speci¢cally inhibited by deoxyribonucleic
acids whose inhibition is dependent on the Tm value of the
nucleic acids.
2. Materials and methods
2.1. Enzymes and reagents
Bovine trypsin, chymotrypsin, and cathepsins B and D were ob-
tained from Sigma (St. Louis, MO, USA). Cathepsin E (CE) was
puri¢ed from rat stomach as described previously [8]. Oligo-
and polynucleotides were of various lengths (6^53 bases) and Tm
values (0^100‡C) including DNA18b (5P-ggctcaggtacccagaga-3P) and
DNA53b (5P-gctctagatcaatgatgatgatgatgatgctggcgtttccgaggggggcgctt-
3P), obtained from Invitrogen (Carlsbad, CA, USA). The following
substrates and reference compounds were obtained from the Peptide
Institute (Osaka, Japan): t-butoxycarbonyl-Gln-Ala-Arg-methylcou-
marinamide (MCA) for trypsin, succinyl-Ala-Ala-Pro-Phe-MCA for
chymotrypsin, z-Arg-Arg-MCA for cathepsin B, Arg-MCA for ca-
thepsin H, Phe-Arg-MCA for cathepsin L, Ala-Ala-Phe-MCA for
tripeptidyl peptidase-I (TPP-I), 7-methoxycoumarin-4-yl-acetyl (MO-
CAc)-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys (Dnp)-D-Arg-NH2
for CD and CE, and 7-amino-4-methyl-coumarin- and MOCAc-Pro-
Leu-Gly for reference compounds. Denatured bovine hemoglobin
(Wako Pure Chemical Ind., Inc., Osaka, Japan) was used for a sub-
strate for CD after being labeled with NaB[3H]4 (Perkin-Elmer Life
Sciences Inc., Boston, MA, USA) according to the method described
previously [9]. A substrate, Gly-Phe-pNA, for cathepsin C was ob-
tained from Sigma.
2.2. Enzyme assay
Measurements of proteolytic activity of CD and CE were per-
formed in a reaction bu¡er: 50 mM sodium acetate bu¡er, pH 4.0,
containing 10 WM of the substrate and 1 Wg/ml of leupeptin, by in-
cubation at 37‡C in the presence or absence of various types of nucleic
acids. The £uorescence intensity of reacted samples at 390 nm
(Ex = 330 nm) was monitored for 15 min at 30 s intervals using a
Biolumin1 960 (Amersham Biosciences AB, Uppsala, Sweden), while
the initial rate was determined from the initial velocity (v) using MO-
CAc-Pro-Leu-Gly as a reference compound. The proteolytic activity
of these enzymes was also measured using a 3H-labeled hemoglobin
according to the modi¢ed method by Anson [10]. Enzyme^substrate
mixtures were incubated in the reaction bu¡er with or without various
concentrations of DNA18b, similar to the above mentioned procedure,
and the reaction was stopped by the addition of 10% trichloroacetic
acid. After centrifugation, radioactivity in supernatants was counted.
The inhibition activity of CD by nucleic acids was also measured at
various concentrations of NaCl. The proteolytic activity of trypsin
and chymotrypsin, and lysosomal cathepsins B, C, H, and L, and
TPP-I was also assayed, as described previously [11^15]. For measure-
ments of inhibition rates of lysosomal proteinases with various con-
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centrations of DNA18b, lysosome-rich fractions were obtained from
mouse livers, as described previously [16].
2.3. Cell culture and transfection
MEFCD3/3 and wild-type (wt) MEF (kind gift from Dr. Paul
Saftig, Go«ttingen, Germany) were cultured in DMEM supplemented
with 10% FBS, 100 Wg/ml streptomycin sulfate, and 100 U/ml peni-
cillin. The cells were seeded 24 h prior to the transfection on a 12 mm
cover glass (Matsunami Glass Ind., Ltd., Tokyo, Japan). DNA18b was
labeled with biotin-16-dUTP (F. Ho¡mann, La Roche Ltd., Basel,
Switzerland) using a terminal deoxynucleotidyl transferase (TOYO-
BO, Tokyo, Japan). Labeled DNA18b was transfected into wt MEF
by the calcium phosphate precipitation method.
To con¢rm the intracellular localization of labeled DNA18b, the
cells were ¢xed with 4% paraformaldehyde bu¡ered with 0.1 M phos-
phate bu¡er, pH 7.4, and then doubly stained with avidin^Texas red
(Nichirei, Tokyo, Japan) and a monoclonal antibody to rat LAMP2
(Developmental Studies Hybridoma Bank, University of Iowa, USA),
a lysosomal membrane protein, at 4‡C overnight. They were further
reacted with anti-rat IgG coupled with FITC (Organon Teknika
Corp., PA, USA) for 1 h and observed by confocal laser microscopy
(LSM-25, Olympus, Tokyo, Japan).
2.4. Puri¢cation of CD inhibitor
MEFCD3/3 harvested from cultures were lysed with a lysis bu¡er
consisting of 0.15 M NaCl, 50 mM Tris^HCl, pH 7.5, 1 mM EDTA,
and 1% Triton X-100, and the lysates were centrifuged at 15 000Ug
for 10 min. The resultant supernatants were applied onto a SP^Seph-
arose (cationic exchange) column equilibrated with 20 mM Tris^HCl
bu¡er, pH 7.0. After washing the column with the same bu¡er, in-
hibiting activity of CD eluted with a linear gradient of 0^1 M NaCl.
Fractions showing inhibiting activity of CD were pooled, adjusted
with phosphate bu¡er to a ¢nal concentration of 20 mM phosphate,
pH 7.0, containing 1 M ammonium sulfate, and then, applied onto a
phenyl^Sepharose (hydrophobic interaction) column equilibrated with
the same bu¡er. After washing the column with the same bu¡er, the
inhibiting substance eluted with a linear gradient of 1^0 M
(NH4)2SO4. The active fractions collected were applied onto a Se-
phacryl H-200R (gel ¢ltration) column equilibrated with 20 mM phos-
phate bu¡er, pH 7.0, containing 0.15 M NaCl and eluted. The active
fractions were pooled and stored at 380‡C until used.
2.5. Subcellular fractionation
The cells transfected with or without DNA18b were washed with
phosphate-bu¡ered saline and homogenized in 0.25 M sucrose by
passing through a 27 gauge needle several times. Lysosome-rich frac-
tions from the homogenates were obtained by previously described
methods [16]. One part of the lysosome-rich fractions was assayed
for the CD activity and the other was analyzed by Western blotting
to determine the protein level of CD in the lysosomal fractions by
measuring the blotted density with a scanning imager (Amersham
Biosciences AB).
3. Results and discussion
3.1. Puri¢cation and characterization of CD inhibitor
The activity of puri¢ed bovine CD which was measured in
the presence of lysates from MEFCD3/3 or the bu¡er solu-
tion, was reduced when lysates of MEFCD3/3 were present.
Cationic exchange chromatography, hydrophobic interaction
chromatography, and gel ¢ltration were performed to purify a
potent CD inhibitor, based on activity measurements. The
inhibiting substance was not detected by SDS^PAGE fol-
lowed by silver staining, but was stained by ethidium bromide
(Fig. 1A). The fraction containing the active substance eluted
near the void volume during gel ¢ltration, where no protein
was detected. These results indicate that the inhibiting sub-
stance of CD activity is a nucleic acid.
Using DNA18b and DNA53b as model DNA fragments,
their ability to inhibit lysosomal proteinases was tested in
lysosome-rich fractions. The activity of lysosomal cysteine
and serine proteinases including cathepsins B, C, H, and L,
and TPP-I was not inhibited by DNA18b, although CD activ-
ity was largely inhibited (Fig. 1B). The inhibition of trypsin
and chymotrypsin, serine proteinases, by these DNA frag-
ments was examined, but no inhibition was detected (data
not shown). Using a £uorogenic substrate, the inhibition of
the bovine CD activity by DNA18b was then analyzed and
found to occur in a dose-dependent manner: a 76.1% inhibi-
tion by 100 nM of DNA18b (Fig. 1C). The complete inhibition
by DNA18b required a concentration of 10 WM, while 1 WM of
DNA53b completely suppressed CD activity (Fig. 1C). The
inhibitory e¡ect of DNA18b on CD activity was also examined
when 3H-labeled hemoglobin was used as a substrate, and was
found to be similar to that obtained by using the £uorogenic
substrate (data not shown). The inhibition by DNAs occurred
at a physiological salt concentration (0.15 M NaCl), but an
increase in ionic strength led to a decrease in inhibition: con-
centrations of DNA18b and plasmid DNA required for a 50%
inhibition of CD activity (IC50) at 0.3 M NaCl were
1.7U1035 M and 1.5U1039 M, respectively, while a concen-
tration of NaCl to give IC50 by 1U1037 M of DNA18b was
0.276 M.
Since the enzymatic characteristics of CD are similar to
those of CE, DNA18b or DNA53b was applied to the enzyme
assay of CE obtained from rat stomach. CE activity was not
inhibited by DNAs, but was rather enhanced, compared to
that incubated without DNAs, when the £uorogenic substrate
was used (Fig. 1D). Similar to the case of CD activity, how-
Fig. 1. Inhibition of CD by nucleic acids. A: A puri¢ed inhibitory
substance (S) was subjected to 0.7% agarose gel electrophoresis (left
panel) and 12.5% SDS^PAGE (right panel), followed by ethidium
bromide (E.B.) and silver staining, respectively. M are marker
DNAs in the left panel and low range marker proteins in right pan-
el. Arrow indicates a puri¢ed DNA fragment. B: DNA18b at a con-
centration of 100 nM does not inhibit the proteolytic activities of
cathepsins B (CB), C (CC), H (CH), and L (CL), and TPP-I in ly-
sosome-rich fractions, except for that of CD. C: Dose-dependent in-
hibition of bovine CD activity by DNA18b and DNA53b. D: Di¡er-
ent e¡ects of DNA18b at a concentration of 100 nM on proteolytic
activity of CE between a £uorogenic substrate (peptide) and 3H-la-
beled hemoglobin. Vertical bars indicate the standard deviation.
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ever, CE activity was inhibited by DNA18b when 3H-labeled
hemoglobin was used as a substrate (Fig. 1D).
3.2. CD activity is inhibited by various deoxyribonucleic acids
To determine the characteristics of deoxyribonucleic acids
that inhibit CD, various types of DNAs were prepared and
their inhibiting activity examined. As shown in Table 1, inhi-
bition of CD activity was observed by a plasmid DNA
(pcDNA3), DNA18b and Escherichia coli genomic DNA.
IC50 di¡ered depending on the DNA masses: larger DNA
masses required lower IC50 values: E. coli genome (4.7
Mbp)s plasmid DNA (5.5 kbp)sDNA18b. Inhibition of
CD activity was detected by both single-stranded and dou-
ble-stranded DNAs, while dNTPs, a mixture of monomeric
DNAs, showed no inhibition. For inhibiting CD activity, the
DNA fragments were required to have at least 10 bases, the
inhibition rate of which was about 40% at a concentration of
100 nM (data not shown).
Since CD activity tended to be inhibited by DNAs of larger
masses, their characteristics were examined further. For this,
various sorts of synthetic oligonucleotides with di¡erent
length (from 18 to 53 bases), GC content (0^100%), and Tm
values (36^75‡C) were prepared. CD activity was measured in
the presence of 100 nM of each oligonucleotide; in each re-
action the initial velocity (v) was determined and the inhibi-
tory rates (%) calculated (Fig. 2). The inhibiting activity was
not simply related to GC content (Fig. 2A) and the length of
oligonucleotides (Fig. 2B), but was signi¢cantly dependent on
the Tm values of each nucleotide (Fig. 2C). The results suggest
that the intensity of inhibition by oligonucleotides is corre-
lated to both GC content and length.
3.3. Endocytosed DNA inhibits CD activity
To examine the issue of whether CD activity is inhibited by
exogenously administered nucleic acids, DNA18b was trans-
fected into wt MEF. Transfected DNA was detected by dou-
ble staining in a granular form and largely co-localized with
LAMP2, a lysosomal membrane marker protein in MEF cy-
toplasm (Fig. 3A). To compare the amounts of CD protein
and its activity, lysosomal fractions were obtained from MEF
before and 12 h after transfection. Although the protein levels
of CD in the cells were similar (Fig. 3B), the speci¢c activity
of CD was signi¢cantly reduced in the transfected cells (Fig.
3C). These results suggest that the CD activity is also sup-
pressed by exogenous DNA.
It has been shown that polynucleotides such as yeast trans-
fer RNA and calf thymus DNA inhibit the activity of human
leucocyte elastase, and that this inhibition is dependent on
ionic strength [17,18]. Moreover, DNA fragments interfere
with the inhibition of human neutrophil-derived cathepsin G
by lung tissue inhibitors, while the inhibition of elastase by the
inhibitors is much less than that of cathepsin G [19]. The
di¡erence in inhibition rates of these proteinases may be at-
tributed to the presence of cationic amino acid residues, such
as arginine, in the vicinity of their active centers [20,21].
The inhibition of the CD activity by DNA18b or DNA53b
was dependent on ionic strength. The content of cationic ami-
no acid residues such as arginine and lysine is high in CD:
8.5% in human CD, 9.3% in rat and mouse CD, and 9% in
bovine CD, indicating that the binding of CD to DNAs may
be due to ionic reactions. The inhibition of CE activity by the
DNA fragments was also analyzed, since CD and CE are
Table 1
Inhibition of CD activity by various types of DNA
DNA Length Strand IC50 (M)
Plasmid 55 kbp double 6U10313
Oligonucleotide 18 mer single 5U1038
dNTPs 1 base single N.D.
E. coli genome 4.7 Mbp double 8U10314
The concentration of CD used is 2.5 nM. The oligonucleotide se-
quence used is 5P-ggctcaggtacccagaga-3P. N.D., not detectable.
Fig. 2. Correlation of inhibitory rates of CD activity and various
synthetic DNA fragments. A,B: Correlation between inhibitory rates
(%) and GC content (A) or length (B). C: Correlation between the
inhibitory rates (%) and Tm values which are calculated from the
equation 60.8+0.41U(GC content (%))3500/(the number of nucleo-
tides). Plotted data show a signi¢cant correlation between the two
parameters and is expressed by an indicated formula as a linear re-
gression line. All assays were performed at least three times. Vertical
bars indicate the standard deviation.
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biochemically and catalytically similar [8,22]. The inhibitory
e¡ect of DNA fragments on CE activity di¡ered depending on
substrates used: CE activity was rather enhanced when the
£uorogenic substrate was used, but it was inhibited when
3H-labeled hemoglobin was used. It is supposed that the elec-
trostatic complexes of DNA fragments and CD or CE do not
hinder all enzyme activity, but have a certain residual activity.
In the case of CD activity, this residual enzyme activity may
be small for both a synthetic substrate and hemoglobin, since
the inhibitory e¡ect of DNA fragments did not di¡er between
substrates used. In the case of CE activity, however, the re-
sidual activity may be enough for a small synthetic substrate,
but not for hemoglobin with a larger molecular size.
A variety of inhibitors of aspartic proteinases in plant, as-
caris and yeast are known [23^25], but most inhibitors are
e¡ective on aspartic proteinases, except for the ascaris inhib-
itor which is speci¢c to pepsin and CE [24]. To date, however,
no reports have appeared on a speci¢c inhibitor of CD in
mammalian cells and tissues, except for this report. Similar
to the ascaris inhibitor, DNAs with high Tm values are potent
inhibitors of CD.
The present study shows that transfected DNA18b partially
inhibits the CD activity in MEF. Phagocytic cells such as
macrophages and microglial cells often ingest cell debris de-
rived from necrosis and apoptosis at in£ammatory or dam-
aged tissue sites, suggesting the possibility that the CD activity
in these phagocytes is inhibited by ingested DNAs.
Moreover, we have previously shown that CD de¢ciency
induces the accumulation of ceroid-lipofuscin in neurons of
the central nervous system and iNOS in microglial cells and
macrophages which leads to neuronal and small intestinal ep-
ithelial cell death [6,7]. These lines of evidence suggest that
phagocytic cells which ingest DNAs may partly contribute to
the production of cytocidal cytokines such as NO via iNOS
activity in in£ammatory and damaged tissue sites.
Thus, DNAs with high Tm values are potent inhibitors of
CD in vitro and partly in vivo.
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Fig. 3. Inhibition of CD activity in wt MEF by transfected
DNA18b. A: Double staining of biotinylated DNA18b and LAMP2,
a lysosomal membrane protein, in MEF 12 h after transfection. Yel-
low color indicates the co-localization of DNA18b with LAMP2 in
the cell. Bar indicates 10 Wm. B: CD protein bands in lysosome-rich
fractions obtained from wt MEF (control) and the cells 12 h after
transfection with DNA18b by Western blot. C: Relative activity of
CD in lysosome-rich fractions obtained from control and DNA18b-
transfected cells. All assays were performed at least three times. Ver-
tical bars indicate the standard deviation.
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